Tilak Mandadi is EVP, Chief Experience & Tech of CVS HEALTH Corp. Currently has a direct ownership of 43,503 shares of CVS, which is worth approximately $2.95 Million. The most recent transaction as insider was on Apr 01, 2025, when has been sold 995 shares (Common Stock) at a price of $67.98 per share, resulting in proceeds of $67,640. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.5K
56.39% 3M change
47.53% 12M change
Total Value Held $2.95 Million

Tilak Mandadi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 01 2025
SELL
Payment of exercise price or tax liability
$67,640 $67.98 p/Share
995 Reduced 2.24%
43,503 Common Stock
Apr 01 2025
BUY
Grant, award, or other acquisition
$1,399,980 $67.98 p/Share
20,594 Added 15.05%
116,257 Common Stock (RSU)
Nov 30 2024
BUY
Grant, award, or other acquisition
$2,999,981 $59.85 p/Share
50,125 Added 33.45%
99,747 Common Stock (RSU)
Aug 31 2024
SELL
Payment of exercise price or tax liability
$749,672 $57.24 p/Share
13,097 Reduced 24.48%
40,414 Common Stock
Apr 01 2024
BUY
Grant, award, or other acquisition
-
16,339 Added 16.46%
82,904 Common Stock (RSU)
Aug 31 2023
SELL
Payment of exercise price or tax liability
$850,664 $65.17 p/Share
13,053 Reduced 39.22%
20,229 Common Stock
Aug 31 2022
BUY
Grant, award, or other acquisition
-
99,847 Added 50.0%
99,847 Common Stock (RSU)

Also insider at

MGM
MGM Resorts International Consumer Cyclical
TM

Tilak Mandadi

EVP, Chief Experience & Tech
Las Vegas, NV

Track Institutional and Insider Activities on CVS

Follow CVS HEALTH Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CVS shares.

Notify only if

Insider Trading

Get notified when an Cvs Health Corp insider buys or sells CVS shares.

Notify only if

News

Receive news related to CVS HEALTH Corp

Track Activities on CVS